Chronic airflow obstruction is a persistent limitation of airflow through the airways, most commonly associated with chronic obstructive pulmonary disease (COPD), characterized by progressive breathing difficulty that is not fully reversible. Research published in this journal addresses several clinical dimensions o…
Chronic airflow obstruction is a persistent limitation of airflow through the airways, most commonly associated with chronic obstructive pulmonary disease (COPD), characterized by progressive breathing difficulty that is not fully reversible. Research published in this journal addresses several clinical dimensions of this condition, including the relationship between COPD and systemic complications such as microalbuminuria in hypoxemic patients, which may reflect broader cardiovascular and renal involvement beyond the respiratory system. Studies have examined spirometric patterns in specific populations, including people living with HIV receiving antiretroviral therapy, recognizing that chronic airflow obstruction can affect diverse patient groups with complex medical backgrounds. The journal has also published work on therapeutic interventions for severe emphysema, specifically bronchoscopic lung volume reduction using one-way valves, representing advances in minimally invasive treatment options for patients with advanced disease. This topic matters because chronic airflow obstruction affects millions worldwide, contributes substantially to morbidity and mortality, and requires ongoing investigation into its systemic effects, occurrence in varied populations, and evolving treatment strategies to improve patient outcomes and quality of life.
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.